Search results
Results from the WOW.Com Content Network
Comparison of the nonsteroidal antiandrogen (NSAA) bicalutamide with other antiandrogens reveals differences between the medications in terms of efficacy, tolerability, safety, and other parameters. Relative to the other first-generation NSAAs , flutamide and nilutamide , bicalutamide shows improved potency , efficacy, tolerability, and safety ...
Comparison to oral morphine [a] Analgesic Strength (relative) Equivalent dose (10 mg oral morphine) [b] Bioavailability Half-life of active metabolites (hours) Oral-to-parenteral ratio Speed of onset Duration Paracetamol (non-opioid) 1 ⁄ 360: 3600 mg 63–89% 1–4 37 min ; 8 min 5–6 hours Aspirin (NSAID, non-opioid) 1 ⁄ 360: 3600 mg 80 ...
[1] [218] In men receiving 150 mg/day bicalutamide, concentrations of (R)-bicalutamide in semen were 4.9 μg/mL (11 μmol/L), and the amount of the drug that could potentially be delivered to a female partner during sexual intercourse is regarded as low (estimated at 0.3 μg/kg) and below the amount that is required to induce changes in the ...
In comparison with the smaller dose, finasteride 5mg had a few additional prominent side effects, and a slightly higher severity of the side effects seen in the 1mg dose.
The term dosage form may also sometimes refer only to the pharmaceutical formulation of a drug product's constituent substances, without considering its final configuration as a consumable product (e.g., capsule, patch, etc.). Due to the somewhat ambiguous nature and overlap of these terms within the pharmaceutical industry, caution is ...
Research shows that a dosage of 20mg is particularly effective for men with severe ED. Clinical trials show that side effects from tadalafil are slightly more common at this dosage than at a lower ...
The drug is described as a relatively weak androgen with partial activity and is rarely used for the purpose of androgen replacement therapy, but is still widely used in medicine. [2] [12] [15] [3] Mesterolone is used in androgen replacement therapy at a dosage of 50 to 100 mg 2 to 3 times per day. [16
It is the fraction of exposure to a drug (AUC) through non-intravenous administration compared with the corresponding intravenous administration of the same drug. [17] The comparison must be dose normalized (e.g., account for different doses or varying weights of the subjects); consequently, the amount absorbed is corrected by dividing the ...